Inga Greblikiene

Inga Greblikiene is a seasoned medical director specializing in drug safety and pharmacovigilance, currently serving at Neurocrine Biosciences since May 2022, where responsibilities include leading safety reporting, signal detection, and causality assessments for clinical studies. Previous roles include Safety and Pharmacovigilance Lead at Biosplice Therapeutics and Medical Director of Pharmacovigilance and Safety at Paradigm Biopharmaceuticals and Retrophin, focusing on compliance with regulatory requirements and conducting safety evaluations. Inga also worked as an independent consultant in pharmacovigilance and safety. Educational qualifications include an MD in Pediatrics from Vilnius University and a certification as a Laser Therapy Technician from Meditech International School.